OCSLOaktree Specialty Lending
About Oaktree Specialty Lending
Oaktree Specialty Lending (NASDAQ:OCSL) operates in the financial sector, focusing on providing flexible and innovative capital solutions to middle-market companies across a wide array of industries. Specializing in direct loans, it seeks to help businesses achieve their objectives by offering first and second lien loans, unsecured loans, and preferred equity. The company aims to generate stable, income-driven returns for its investors while prioritizing capital preservation. Its project portfolio reflects a diverse mix of investments that are strategically selected to balance risk and reward. Oaktree Specialty Lending is dedicated to fostering growth and financial stability for its clients, exemplifying a commitment to excellence and strategic investment insights.
What is OCSL known for?
Snapshot
Public US
Ownership
2007
Year founded
1514
Employees
Los Angeles, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
Los Angeles, US
Products and/or services of Oaktree Specialty Lending
- Middle-market lending: Provides flexible, customized financing solutions to mid-sized companies for growth, acquisitions, recapitalizations, and working capital.
- Syndicated loans: Participates in syndicated credit facilities as a lender for larger, diversified transactions.
- Equity co-investments: Invests in equity alongside its debt investments in portfolio companies to capitalize on growth opportunities.
- Second lien loans: Offers secured debt that ranks below senior loans and ahead of equity, used for leveraged buyouts and corporate refinancing.
- Mezzanine financing: Provides subordinated debt with equity features to bridge financing gaps for companies seeking less dilutive capital solutions.
- Portfolio management: Monitors and actively manages investments, optimizing returns while managing risk, through comprehensive analysis and strategic advisory.
Oaktree Specialty Lending executive team
- Mr. Armen Panossian J.D.CEO & Co-Chief Investment Officer
- Mr. Mathew M. PendoPresident
- Dr. Aman Kumar M.D.Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending
- Mr. Christopher McKownCFO & Treasurer
- Mr. Brett McKeoneChief Operating Officer
- Mr. Raghav KhannaCo-Chief Investment Officer
- Mr. Dane KlevenSenior VP & Head of Investor Relations
- Ms. Mary Gallegly J.D.MD,General Counsel & Secretary
- Ms. Ashley PakChief Compliance Officer
- Mr. Sandeep Kumar KhoranaManaging Director of Origination